marketcaparena
Search

    NVAX

    NOVAVAX INC

    Company overview

    Market capitalization
    $1.78B
    Employees
    749
    Latest publication
    2026-09-29
    About NOVAVAX INC

    Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20252025-12-31 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ2 20242024-06-30 · USDQ2 20232023-06-30 · USDQ1 20232023-03-31 · USDQ1 20222022-03-31 · USD
    Total Revenue56,698,000USD147,139,000USD239,240,000USD666,655,000USD415,484,000USD424,426,000USD-6,428,000USD604,670,000USD
    Cost Of Revenue14,246,000USD25,204,000USD14,225,000USD14,115,000USD46,242,000USD55,777,000USD34,086,000USD15,204,000USD
    Gross Profit42,452,000USD121,935,000USD225,015,000USD652,540,000USD369,242,000USD368,649,000USD-40,514,000USD589,466,000USD
    Research Development70,693,000USD73,976,000USD77,633,000USD88,937,000USD106,946,000USD219,475,000USD247,101,000USD383,483,000USD
    Selling General Administrative26,665,000USD34,122,000USD43,612,000USD48,090,000USD101,298,000USD93,717,000USD112,532,000USD95,992,000USD
    Total Operating Expenses97,358,000USD100,915,000USD119,345,000USD137,027,000USD208,244,000USD313,192,000USD272,254,000USD380,174,000USD
    Operating Income-54,906,000USD21,020,000USD105,670,000USD515,513,000USD160,998,000USD55,457,000USD-312,768,000USD209,292,000USD
    Total Other Income Expense Net3,230,000USD-3,117,000USD1,784,000USD4,333,000USD3,588,000USD2,408,000USD20,046,000USD-3,222,000USD
    Interest Expense5,689,000USD5,824,000USD5,518,000USD5,723,000USD4,143,000USD3,124,000USD4,316,000USD4,876,000USD
    Income Before Tax-51,676,000USD17,903,000USD107,454,000USD519,846,000USD164,586,000USD57,865,000USD-292,722,000USD206,070,000USD
    Income Tax Expense1,711,000USD376,000USD946,000USD1,200,000USD2,205,000USD-143,000USD1,183,000USD2,662,000USD
    Net Income-53,387,000USD17,527,000USD106,508,000USD518,646,000USD162,381,000USD58,008,000USD-293,905,000USD203,408,000USD
    Unclassified Operating Expenses—-7,183,000USD-1,900,000USD———-87,379,000USD-99,301,000USD
    Net Interest Income—-5,824,000USD-5,518,000USD-5,723,000USD-4,143,000USD-3,124,000USD-4,316,000USD-4,876,000USD
    Tax Provision—376,000USD946,000USD1,200,000USD2,205,000USD-143,000USD1,183,000USD2,662,000USD
    Net Income From Continuing Ops—17,527,000USD106,508,000USD518,646,000USD162,381,000USD58,008,000USD-293,905,000USD203,408,000USD
    Ebit—23,727,000USD112,972,000USD525,569,000USD168,729,000USD60,989,000USD-288,406,000USD210,946,000USD
    Ebitda—28,852,000USD120,535,000USD533,909,000USD179,861,000USD71,056,000USD-279,363,000USD217,711,000USD
    Depreciation And Amortization—5,125,000USD7,563,000USD8,340,000USD11,132,000USD10,067,000USD9,043,000USD6,765,000USD
    Reconciled Depreciation—5,125,000USD7,563,000USD8,340,000USD11,132,000USD10,067,000USD9,043,000USD6,765,000USD
    Net Income Applicable To Common Shares—————58,008,000USD58,008,000USD203,408,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20162016-12-31 · USDFY 20102010-12-31 · USDFY 20092009-12-31 · USD
    Total Revenue1,123,479,000USD1,146,290,000USD475,598,000USD18,662,000USD34,288,000USD15,353,000USD343,000USD325,000USD
    Cost Of Revenue71,140,000USD12,661,000USD747,027,000USD113,842,000USD173,797,000USD237,939,000USD37,465,000USD36,514,000USD
    Gross Profit1,052,339,000USD1,146,290,000USD475,598,000USD-95,180,000USD34,288,000USD-222,586,000USD343,000USD325,000USD
    Research Development336,820,000USD2,534,508,000USD747,027,000USD113,842,000USD173,797,000USD237,939,000USD28,032,000USD25,780,000USD
    Selling General Administrative157,479,000USD298,358,000USD145,290,000USD34,417,000USD34,409,000USD46,527,000USD10,805,000USD11,928,000USD
    Unclassified Operating Expenses-5,231,000USD———————
    Total Operating Expenses489,068,000USD2,832,866,000USD892,317,000USD148,259,000USD208,206,000USD284,466,000USD38,837,000USD37,708,000USD
    Operating Income563,271,000USD-1,686,576,000USD-416,719,000USD-120,581,000USD-173,918,000USD-269,113,000USD-38,494,000USD-37,383,000USD
    Interest Expense22,547,000USD21,127,000USD15,145,000USD13,612,000USD12,188,000USD12,965,000USD9,000USD501,000USD
    Net Interest Income-22,547,000USD-21,127,000USD-15,145,000USD-13,612,000USD-13,612,000USD-12,965,000USD——
    Income Before Tax442,167,000USD-1,714,536,000USD-418,259,000USD-132,694,000USD-184,748,000USD-279,966,000USD-36,158,000USD-38,374,000USD
    Income Tax Expense1,865,000USD29,215,000USD9,246,000USD-2,592,000USD1,358,000USD2,317,000USD-450,000USD-203,000USD
    Tax Provision1,865,000USD29,215,000USD0USD—————
    Net Income440,302,000USD-1,743,751,000USD-427,505,000USD-130,102,000USD-184,748,000USD-279,966,000USD-35,708,000USD-38,374,000USD
    Net Income From Continuing Ops440,302,000USD-1,743,751,000USD-418,259,000USD-132,694,000USD-184,748,000USD-279,966,000USD——
    Ebit464,714,000USD-1,686,576,000USD-416,719,000USD-119,082,000USD-173,918,000USD-269,113,000USD-37,080,000USD-39,568,000USD
    Ebitda492,327,000USD-1,673,915,000USD-411,834,000USD-113,282,000USD-165,759,000USD-260,608,000USD-35,708,000USD-38,374,000USD
    Depreciation And Amortization27,613,000USD12,661,000USD4,885,000USD5,800,000USD8,159,000USD8,505,000USD1,372,000USD1,194,000USD
    Reconciled Depreciation27,613,000USD12,661,000USD4,885,000USD5,676,000USD8,159,000USD———
    Total Other Income Expense Net-121,104,000USD-27,960,000USD-1,540,000USD-12,113,000USD108,000USD-31,000USD2,336,000USD-991,000USD
    Non Operating Income Net Other—-6,833,000USD13,605,000USD1,499,000USD2,782,000USD2,112,000USD——
    Net Income Applicable To Common Shares—-1,743,751,000USD-418,259,000USD-132,694,000USD-184,748,000USD-279,966,000USD——
    Interest Income———12,100,000USD10,938,000USD10,822,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets955,575,000USD1,043,162,000USD1,176,512,000USD1,179,889,000USD1,336,549,000USD1,292,992,000USD1,560,418,000USD1,712,483,000USD
    Cash And Equivalents191,458,000USD———————
    Cash And Short Term Investments719,340,000USD790,332,000USD735,084,000USD762,894,000USD612,304,000USD731,479,000USD923,118,000USD909,531,000USD
    Short Term Investments527,882,000USD561,969,000USD494,450,000USD494,871,000USD358,560,000USD468,141,000USD392,888,000USD335,901,000USD
    Total Current Assets771,098,000USD850,816,000USD978,276,000USD974,590,000USD919,512,000USD868,028,000USD1,128,942,000USD1,103,680,000USD
    Other Current Assets23,013,000USD25,714,000USD125,201,000USD164,011,000USD70,572,000USD81,776,000USD88,790,000USD90,549,000USD
    Other Non Current Assets13,960,000USD———————
    Total Liabilities1,146,282,000USD———————
    Total Current Liabilities330,574,000USD342,461,000USD459,950,000USD429,869,000USD389,138,000USD422,170,000USD1,154,416,000USD1,180,999,000USD
    Other Current Liabilities135,527,000USD———————
    Other Non Current Liabilities165,744,000USD———————
    Total Stockholder Equity-190,707,000USD-144,762,000USD-127,753,000USD-156,672,000USD37,625,000USD-75,643,000USD-623,841,000USD-526,436,000USD
    Total Equity Including Noncontrolling Interest-190,707,000USD———————
    Deferred Revenue86,577,000USD———————
    Deferred Revenue Non Current356,755,000USD———————
    Inventory10,006,000USD11,458,000USD11,545,000USD13,511,000USD10,240,000USD10,263,000USD8,749,000USD8,638,000USD
    Property Plant Equipment Net38,133,000USD63,507,000USD67,697,000USD72,993,000USD282,687,000USD291,033,000USD299,998,000USD451,490,000USD
    Goodwill112,542,000USD———————
    Accounts Payable22,936,000USD16,101,000USD24,578,000USD15,227,000USD50,595,000USD34,162,000USD41,579,000USD57,517,000USD
    Common Stock1,682,000USD1,678,000USD1,650,000USD1,648,000USD1,645,000USD1,642,000USD1,619,000USD1,616,000USD
    Retained Earnings-4,631,026,000USD-4,577,639,000USD-4,568,148,000USD-4,585,675,000USD-4,383,296,000USD-4,489,804,000USD-5,008,450,000USD-4,927,420,000USD
    Accumulated Other Comprehensive Income-7,448,000USD-5,074,000USD2,010,000USD-1,745,000USD-458,000USD1,608,000USD-22,559,000USD3,598,000USD
    Total Liab—1,187,924,000USD1,304,265,000USD1,336,561,000USD1,298,924,000USD1,368,635,000USD2,184,259,000USD2,238,919,000USD
    Other Current Liab—235,476,000USD292,812,000USD305,355,000USD219,228,000USD274,196,000USD430,761,000USD500,389,000USD
    Capital Stock—1,678,000USD1,650,000USD1,648,000USD1,645,000USD1,642,000USD1,619,000USD1,616,000USD
    Good Will—112,888,000USD113,462,000USD113,080,000USD112,958,000USD112,027,000USD107,478,000USD126,766,000USD
    Cash—228,363,000USD240,634,000USD268,023,000USD253,744,000USD263,338,000USD530,230,000USD573,630,000USD
    Current Deferred Revenue—88,772,000USD140,053,000USD104,251,000USD113,763,000USD108,334,000USD675,067,000USD613,418,000USD
    Net Debt—66,695,000USD8,177,000USD-16,883,000USD-25,254,000USD-34,679,000USD-299,811,000USD-340,322,000USD
    Short Term Debt—2,112,000USD2,507,000USD5,036,000USD5,552,000USD5,478,000USD7,009,000USD9,675,000USD
    Short Long Term Debt Total—295,058,000USD248,811,000USD251,140,000USD228,490,000USD228,659,000USD230,419,000USD233,308,000USD
    Long Term Debt—291,039,000USD244,213,000USD243,835,000USD170,568,000USD170,126,000USD169,684,000USD169,265,000USD
    Net Receivables—23,312,000USD106,446,000USD34,174,000USD226,396,000USD44,510,000USD108,285,000USD94,962,000USD
    Property Plant Equipment Gross—63,507,000USD108,318,000USD72,993,000USD282,687,000USD291,033,000USD349,155,000USD451,490,000USD
    Common Stock Shares Outstanding—163,276,000shares173,103,000shares162,353,000shares177,215,000shares177,625,000shares160,241,000shares160,049,000shares
    Non Current Assets Total—192,346,000USD198,236,000USD205,299,000USD417,037,000USD424,964,000USD431,476,000USD608,803,000USD
    Non Current Liabilities Total—845,463,000USD844,315,000USD906,692,000USD909,786,000USD946,465,000USD1,029,843,000USD1,057,920,000USD
    Non Current Liabilities Other—193,244,000USD239,068,000USD263,483,000USD287,585,000USD313,727,000USD359,614,000USD318,917,000USD
    Non Currrent Assets Other—15,951,000USD17,077,000USD19,226,000USD21,392,000USD21,904,000USD24,000,000USD30,547,000USD
    Net Working Capital—508,355,000USD518,326,000USD544,721,000USD530,374,000USD445,858,000USD-25,474,000USD-77,319,000USD
    Unclassified Non Current Liabilities—361,180,000USD361,034,000USD399,374,000USD451,633,000USD462,612,000USD500,545,000USD569,738,000USD
    Unclassified Equity—4,434,595,000USD4,435,085,000USD4,427,452,000USD4,418,089,000USD4,409,269,000USD4,403,930,000USD4,394,154,000USD
    Other Assets——————-42,248,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets1,176,512,000USD1,560,418,000USD1,797,490,000USD2,258,679,000USD2,576,753,000USD1,582,479,000USD172,957,000USD207,978,000USD
    Other Current Assets125,201,000USD88,790,000USD236,447,000USD247,450,000USD176,138,000USD441,816,000USD10,924,000USD107,471,000USD
    Total Liab1,304,265,000USD2,184,259,000USD2,514,417,000USD2,892,757,000USD2,928,426,000USD955,270,000USD358,974,000USD375,913,000USD
    Total Stockholder Equity-127,753,000USD-623,841,000USD-716,927,000USD-634,078,000USD-351,673,000USD627,209,000USD-186,017,000USD-167,935,000USD
    Other Current Liab292,812,000USD430,761,000USD1,256,076,000USD1,521,213,000USD709,792,000USD-327,560,000USD19,945,000USD1,600,000USD
    Common Stock1,650,000USD1,619,000USD1,405,000USD868,000USD764,000USD714,000USD324,000USD3,849,000USD
    Capital Stock1,650,000USD1,619,000USD1,405,000USD868,000USD764,000USD714,000USD324,000USD3,849,000USD
    Retained Earnings-4,568,148,000USD-5,008,450,000USD-4,820,951,000USD-4,275,889,000USD-3,617,950,000USD-1,874,199,000USD-1,431,801,000USD-1,299,107,000USD
    Good Will113,462,000USD107,478,000USD127,454,000USD126,331,000USD131,479,000USD135,379,000USD51,154,000USD51,967,000USD
    Cash240,634,000USD530,230,000USD568,505,000USD1,336,883,000USD1,515,116,000USD553,398,000USD78,823,000USD70,154,000USD
    Cash And Short Term Investments735,084,000USD923,118,000USD568,505,000USD1,336,883,000USD1,515,116,000USD711,047,000USD78,823,000USD70,154,000USD
    Total Current Assets978,276,000USD1,128,942,000USD1,143,888,000USD1,703,391,000USD2,155,119,000USD1,248,203,000USD97,247,000USD119,276,000USD
    Total Current Liabilities459,950,000USD1,154,416,000USD1,635,138,000USD2,459,944,000USD2,390,319,000USD322,035,000USD25,795,000USD45,539,000USD
    Current Deferred Revenue140,053,000USD675,067,000USD241,310,000USD370,137,000USD1,422,944,000USD273,228,000USD1,678,000USD10,010,000USD
    Net Debt8,177,000USD-299,811,000USD-339,424,000USD-787,102,000USD-1,061,125,000USD-231,363,000USD243,050,000USD249,033,000USD
    Short Term Debt2,507,000USD7,009,000USD5,142,000USD352,077,000USD130,533,000USD322,035,000USD1,262,000USD24,628,000USD
    Short Long Term Debt Total248,811,000USD230,419,000USD229,081,000USD549,781,000USD453,991,000USD322,035,000USD321,873,000USD343,815,000USD
    Long Term Debt244,213,000USD169,684,000USD168,016,000USD166,466,000USD323,458,000USD322,035,000USD320,611,000USD319,187,000USD
    Short Term Investments494,450,000USD392,888,000USD10,424,000USD—0USD157,649,000USD0USD21,980,000USD
    Net Receivables106,446,000USD108,285,000USD297,240,000USD82,375,000USD454,993,000USD262,012,000USD7,500,000USD-70,323,000USD
    Inventory11,545,000USD8,749,000USD41,696,000USD36,683,000USD8,872,000USD-166,672,000USD-82,966,000USD11,974,000USD
    Accounts Payable24,578,000USD41,579,000USD132,610,000USD216,517,000USD127,050,000USD54,332,000USD2,910,000USD9,301,000USD
    Property Plant Equipment Net67,697,000USD299,998,000USD490,989,000USD400,488,000USD228,696,000USD179,954,000USD11,445,000USD28,426,000USD
    Property Plant Equipment Gross108,318,000USD349,155,000USD565,957,000USD447,780,000USD258,598,000USD179,954,000USD11,445,000USD28,426,000USD
    Accumulated Other Comprehensive Income2,010,000USD-22,559,000USD2,722,000USD-6,377,000USD-1,353,000USD7,024,000USD-12,508,000USD-11,191,000USD
    Common Stock Shares Outstanding173,103,000shares152,190,000shares100,768,000shares78,183,000shares74,400,000shares57,554,000shares24,100,000shares18,487,850shares
    Non Current Assets Total198,236,000USD431,476,000USD653,602,000USD555,288,000USD421,634,000USD334,276,000USD75,710,000USD88,702,000USD
    Non Current Liabilities Total844,315,000USD1,029,843,000USD879,279,000USD432,813,000USD538,107,000USD633,235,000USD333,179,000USD330,374,000USD
    Non Current Liabilities Other239,068,000USD359,614,000USD33,130,000USD55,695,000USD214,649,000USD40,083,000USD10,068,000USD8,687,000USD
    Non Currrent Assets Other17,077,000USD24,000,000USD35,159,000USD28,469,000USD56,689,000USD13,218,000USD7,530,000USD1,768,000USD
    Net Working Capital518,326,000USD-25,474,000USD-491,250,000USD-756,553,000USD-235,200,000USD668,531,000USD71,452,000USD73,737,000USD
    Unclassified Non Current Liabilities361,034,000USD500,545,000USD678,133,000USD25,628,000USD-175,533,000USD267,759,000USD—-11,187,000USD
    Unclassified Equity4,435,085,000USD4,403,930,000USD4,098,492,000USD3,646,452,000USD3,351,203,000USD2,534,762,000USD1,260,227,000USD1,137,115,000USD
    Other Assets——-57,852,000USD28,469,000USD16,566,000USD5,424,000USD1,076,000USD1,768,000USD
    Other Liab———185,024,000USD175,533,000USD3,358,000USD2,564,000USD11,187,000USD
    Short Long Term Debt———324,881,000USD—322,035,000USD——
    Net Tangible Assets———-760,409,000USD-487,922,000USD486,105,000USD-242,752,000USD-226,443,000USD
    Unclassified Non Current Assets———-28,469,000USD-16,566,000USD-5,424,000USD-1,076,000USD-1,768,000USD
    Unclassified Current Liabilities———-324,881,000USD—-649,595,000USD——
    Intangible Assets————4,770,000USD5,725,000USD5,581,000USD6,541,000USD
    Treasury Stock————-85,101,000USD-41,806,000USD-2,583,000USD-2,450,000USD
    Unclassified Current Assets—————-166,672,000USD—-92,303,000USD
    Deferred Long Term Liab——————2,500,000USD2,500,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-9,491,000USD17,527,000USD-202,379,000USD106,508,000USD518,646,000USD-81,030,000USD-121,300,000USD162,381,000USD
    Depreciation3,062,000USD5,125,000USD6,585,000USD7,563,000USD8,340,000USD12,517,000USD12,700,000USD11,132,000USD
    Stock Based Compensation7,724,000USD7,967,000USD8,549,000USD9,214,000USD10,285,000USD10,448,000USD12,049,000USD14,099,000USD
    Other Non Cash Items-8,706,000USD3,608,000USD129,122,000USD-10,416,000USD16,826,000USD-66,452,000USD4,104,000USD11,427,000USD
    Change To Account Receivables86,243,000USD-51,940,000USD207,927,000USD-168,814,000USD73,867,000USD913,000USD-37,590,000USD94,712,000USD
    Change To Inventory-226,000USD2,148,000USD-3,753,000USD-4,010,000USD2,375,000USD-189,000USD-1,073,000USD-2,643,000USD
    Change In Working Capital-25,012,000USD-73,702,000USD165,927,000USD-240,331,000USD-739,599,000USD-48,646,000USD-52,367,000USD115,230,000USD
    Total Cash From Operating Activities-32,423,000USD-39,475,000USD107,804,000USD-127,462,000USD-185,502,000USD-173,163,000USD-144,814,000USD314,269,000USD
    Capital Expenditures-1,270,000USD-2,076,000USD-2,017,000USD-247,000USD-1,595,000USD-2,252,000USD-2,012,000USD-3,125,000USD
    Free Cash Flow-33,693,000USD-41,551,000USD105,787,000USD-127,709,000USD-187,097,000USD-175,415,000USD-146,826,000USD311,144,000USD
    Investments-66,841,000USD3,079,000USD-136,529,000USD111,098,000USD-73,319,000USD144,007,000USD31,912,000USD-372,707,000USD
    Total Cashflows From Investing Activities-28,361,000USD20,483,000USD-136,529,000USD111,098,000USD-73,319,000USD144,007,000USD31,912,000USD-372,707,000USD
    Net Borrowings45,833,000USD-6,274,000USD41,622,000USD-612,000USD-2,201,000USD-2,756,000USD-512,000USD—
    Total Cash From Financing Activities37,675,000USD-6,604,000USD42,442,000USD-1,040,000USD-7,061,000USD-3,422,000USD-97,000USD258,216,000USD
    Sale Purchase Of Stock-8,157,999USD-330,000USD820,000USD-5,288,000USD————
    Change In Cash-23,147,000USD-27,305,000USD14,346,000USD-9,498,000USD-266,812,000USD-43,295,000USD-106,971,000USD199,622,000USD
    Begin Period Cash Flow251,510,000USD283,357,000USD264,493,000USD278,480,000USD545,292,000USD588,587,000USD695,558,000USD495,936,000USD
    End Period Cash Flow228,363,000USD256,052,000USD278,839,000USD268,982,000USD278,480,000USD545,292,000USD588,587,000USD695,558,000USD
    Other Cashflows From Investing Activities39,750,000USD19,480,000USD—-280,000USD-375,000USD192,643,000USD104,345,000USD-369,582,000USD
    Other Cashflows From Financing Activities37,675,000USD-6,604,000USD42,442,000USD4,860,000USD-4,860,000USD-666,000USD415,000USD2,172,000USD
    Unclassified Financing Cash Flow-37,675,001USD6,604,000USD-42,442,000USD—————
    Issuance Of Capital Stock—0USD0USD0USD0USD0USD0USD256,410,000USD
    Unclassified Investing Cash Flow——2,017,000USD—1,970,000USD-190,391,000USD-102,333,000USD372,707,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USD
    Net Income440,302,000USD-187,499,000USD-545,062,000USD-657,939,000USD-1,743,751,000USD-184,748,000USD-183,769,000USD-279,966,000USD
    Depreciation27,613,000USD48,496,000USD41,225,000USD29,054,000USD12,661,000USD8,159,000USD9,817,000USD8,505,000USD
    Stock Based Compensation36,015,000USD48,152,000USD85,357,000USD130,300,000USD183,626,000USD18,314,000USD19,809,000USD19,160,000USD
    Other Non Cash Items139,140,000USD-44,894,000USD81,349,000USD443,798,000USD136,792,000USD-5,353,000USD6,072,000USD3,931,000USD
    Change To Account Receivables61,040,000USD354,089,000USD-274,442,000USD249,166,000USD-192,265,000USD1,212,000USD1,212,000USD2,072,000USD
    Change To Inventory-3,240,000USD12,914,000USD-74,457,000USD-477,801,000USD-600,326,000USD—0USD-1,979,000USD
    Change In Working Capital-887,705,000USD48,482,000USD-376,836,000USD-361,150,000USD1,733,618,000USD-21,142,000USD9,106,000USD-7,471,000USD
    Total Cash From Operating Activities-244,635,000USD-87,263,000USD-713,967,000USD-415,937,000USD322,946,000USD-184,825,000USD-138,696,000USD-255,467,000USD
    Capital Expenditures-5,560,000USD-13,057,000USD-58,806,000USD-92,985,000USD-57,486,000USD-1,372,000USD-4,189,000USD-18,213,000USD
    Free Cash Flow-250,195,000USD-100,320,000USD-772,773,000USD-508,922,000USD265,460,000USD-186,197,000USD-142,885,000USD-273,680,000USD
    Investments-91,532,000USD-204,038,000USD-71,792,000USD-92,985,000USD157,640,000USD29,968,000USD40,157,000USD46,219,000USD
    Total Cashflows From Investing Activities-78,267,000USD-204,038,000USD-58,806,000USD-92,985,000USD100,154,000USD28,596,000USD35,968,000USD28,017,000USD
    Net Borrowings32,535,000USD-3,994,000USD-352,345,000USD81,655,000USD-127,907,000USD-96,065,000USD-37,000USD313,749,000USD
    Total Cash From Financing Activities27,737,000USD260,583,000USD4,466,000USD324,988,000USD461,713,000USD102,805,000USD64,540,000USD279,030,000USD
    Sale Purchase Of Stock-4,798,000USD———589,620,000USD102,805,000USD64,577,000USD3,802,000USD
    Issuance Of Capital Stock0USD263,272,000USD326,840,000USD249,230,000USD564,859,000USD100,060,000USD——
    Change In Cash-289,240,000USD-38,518,000USD-765,035,000USD-179,414,000USD879,521,000USD-53,472,000USD-38,046,000USD51,245,000USD
    Begin Period Cash Flow545,292,000USD583,810,000USD1,348,845,000USD1,528,259,000USD648,738,000USD135,431,000USD144,353,000USD93,108,000USD
    End Period Cash Flow256,052,000USD545,292,000USD583,810,000USD1,348,845,000USD1,528,259,000USD81,959,000USD106,307,000USD144,353,000USD
    Other Cashflows From Investing Activities18,825,000USD192,643,000USD—-3,929,000USD-57,486,000USD-1,372,000USD-4,189,000USD-18,202,000USD
    Other Cashflows From Financing Activities27,737,000USD1,305,000USD-3,432,000USD-5,897,000USD24,761,000USD2,745,000USD1,152,000USD-49,306,000USD
    Unclassified Financing Cash Flow-27,737,000USD—33,403,000USD—-24,761,000USD93,320,000USD-1,152,000USD10,785,000USD
    Unclassified Investing Cash Flow—-179,586,000USD71,792,000USD96,914,000USD57,486,000USD1,372,000USD4,189,000USD18,213,000USD
    Change To Liabilities———-132,515,000USD1,925,883,000USD-22,354,000USD2,669,000USD-7,690,000USD
    Cash And Cash Equivalents Changes————884,813,000USD-53,424,000USD-38,046,000USD51,245,000USD
    Dividends Paid——————0USD0USD
    Exchange Rate Changes——————142,000USD-335,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyCanada0USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyEurope1,118,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyRest of World17,143,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States38,437,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyCanada0USD0001628280-26-030917
    Q1 2026Quarterly · 2026-03-31GeographyEurope20,146,000USD0001628280-26-030917
    Q1 2026Quarterly · 2026-03-31GeographyRest of World23,275,000USD0001628280-26-030917
    Q1 2026Quarterly · 2026-03-31GeographyUnited States96,093,000USD0001628280-26-030917
    FY 2025Yearly · 2025-12-31GeographyEurope15,740,000USD0001000694-26-000007
    FY 2025Yearly · 2025-12-31GeographyRest Of North America575,670,000USD0001000694-26-000007
    FY 2025Yearly · 2025-12-31GeographyRest of World126,458,000USD0001000694-26-000007
    FY 2025Yearly · 2025-12-31GeographyUnited States405,611,000USD0001000694-26-000007
    Q3 2025Quarterly · 2025-09-30GeographyCanada0USD0001000694-25-000046
    Q3 2025Quarterly · 2025-09-30GeographyEurope655,000USD0001000694-25-000046
    Q3 2025Quarterly · 2025-09-30GeographyRest of World13,014,000USD0001000694-25-000046
    Q3 2025Quarterly · 2025-09-30GeographyUnited States56,776,000USD0001000694-25-000046
    Q2 2025Quarterly · 2025-06-30GeographyCanada0USD0001000694-25-000029
    Q2 2025Quarterly · 2025-06-30GeographyEurope3,627,000USD0001000694-25-000029
    Q2 2025Quarterly · 2025-06-30GeographyRest of World37,430,000USD0001000694-25-000029
    Q2 2025Quarterly · 2025-06-30GeographyUnited States198,183,000USD0001000694-25-000029
    Q2 2025Quarterly · 2025-06-30ProductLicensing Royalties And Other — Cost Reimbursements6,479,000USD0001000694-25-000029
    Q2 2025Quarterly · 2025-06-30ProductLicensing Royalties And Other — Milestone178,434,000USD0001000694-25-000029
    Q2 2025Quarterly · 2025-06-30ProductLicensing Royalties And Other — Supply Sales12,817,000USD0001000694-25-000029
    Q2 2025Quarterly · 2025-06-30ProductLicensing Royalties And Other — Upfront Fee18,500,000USD0001000694-25-000029
    Q2 2025Quarterly · 2025-06-30ProductLicensing Royalties And Other — Upfront Fee Amortization12,268,000USD0001000694-25-000029
    Q2 2025Quarterly · 2025-06-30ProductMilestone Amortization5,665,000USD0001000694-25-000029
    Q2 2025Quarterly · 2025-06-30ProductNuvaxovid Sales-2,093,000USD0001000694-25-000029
    Q2 2025Quarterly · 2025-06-30ProductOther1,870,000USD0001000694-25-000029
    Q2 2025Quarterly · 2025-06-30ProductRoyalty5,000,000USD0001000694-25-000029
    Q2 2025Quarterly · 2025-06-30ProductSupport Services300,000USD0001000694-25-000029
    Q1 2025Quarterly · 2025-03-31GeographyCanada575,670,000USD0001628280-26-030917
    Q1 2025Quarterly · 2025-03-31GeographyEurope8,086,000USD0001628280-26-030917
    Q1 2025Quarterly · 2025-03-31GeographyRest of World43,489,000USD0001628280-26-030917
    Q1 2025Quarterly · 2025-03-31GeographyUnited States39,410,000USD0001628280-26-030917
    FY 2024Yearly · 2024-12-31GeographyEurope96,143,000USD0001000694-26-000007
    FY 2024Yearly · 2024-12-31GeographyRest Of North America4,462,000USD0001000694-26-000007
    FY 2024Yearly · 2024-12-31GeographyRest of World59,022,000USD0001000694-26-000007
    FY 2024Yearly · 2024-12-31GeographyUnited States522,535,000USD0001000694-26-000007
    Q3 2024Quarterly · 2024-09-30GeographyCanada0USD0001000694-25-000046
    Q3 2024Quarterly · 2024-09-30GeographyEurope1,814,000USD0001000694-25-000046
    Q3 2024Quarterly · 2024-09-30GeographyRest of World11,607,000USD0001000694-25-000046
    Q3 2024Quarterly · 2024-09-30GeographyUnited States71,091,000USD0001000694-25-000046
    Q2 2024Quarterly · 2024-06-30GeographyCanada0USD0001000694-25-000029
    Q2 2024Quarterly · 2024-06-30GeographyEurope705,000USD0001000694-25-000029
    Q2 2024Quarterly · 2024-06-30GeographyRest of World20,275,000USD0001000694-25-000029
    Q2 2024Quarterly · 2024-06-30GeographyUnited States394,504,000USD0001000694-25-000029
    Q2 2024Quarterly · 2024-06-30ProductCost Reimbursements0USD0001000694-25-000029
    Q2 2024Quarterly · 2024-06-30ProductLicensing Royalties And Other — Milestone Amortization2,073,000USD0001000694-25-000029
    Q2 2024Quarterly · 2024-06-30ProductLicensing Royalties And Other — Upfront Fee386,250,000USD0001000694-25-000029
    Q2 2024Quarterly · 2024-06-30ProductLicensing Royalties And Other — Upfront Fee Amortization4,573,000USD0001000694-25-000029
    Q2 2024Quarterly · 2024-06-30ProductMilestone0USD0001000694-25-000029
    Q2 2024Quarterly · 2024-06-30ProductNuvaxovid Sales19,904,000USD0001000694-25-000029
    Q2 2024Quarterly · 2024-06-30ProductRoyalty0USD0001000694-25-000029
    Q2 2024Quarterly · 2024-06-30ProductSupply Sales2,684,000USD0001000694-25-000029
    Q2 2024Quarterly · 2024-06-30ProductSupport Services0USD0001000694-25-000029
    Q1 2024Quarterly · 2024-03-31GeographyCanada0USD0001000694-25-000021
    Q1 2024Quarterly · 2024-03-31GeographyEurope90,416,000USD0001000694-25-000021
    Q1 2024Quarterly · 2024-03-31GeographyRest of World9,870,000USD0001000694-25-000021
    Q1 2024Quarterly · 2024-03-31GeographyUnited States-6,431,000USD0001000694-25-000021
    Q1 2024Quarterly · 2024-03-31ProductCost Reimbursements0USD0001000694-25-000021
    Q1 2024Quarterly · 2024-03-31ProductLicensing Royalties And Other4,019,000USD0001000694-25-000021
    Q1 2024Quarterly · 2024-03-31ProductMilestone Amortization0USD0001000694-25-000021
    Q1 2024Quarterly · 2024-03-31ProductNuvaxovid Sales82,324,000USD0001000694-25-000021
    Q1 2024Quarterly · 2024-03-31ProductSupply Sales7,512,000USD0001000694-25-000021
    Q1 2024Quarterly · 2024-03-31ProductUpfront Fee Amortization0USD0001000694-25-000021
    FY 2023Yearly · 2023-12-31GeographyEurope271,964,000USD0001000694-26-000007
    FY 2023Yearly · 2023-12-31GeographyRest Of North America13,388,000USD0001000694-26-000007
    FY 2023Yearly · 2023-12-31GeographyRest of World254,459,000USD0001000694-26-000007
    FY 2023Yearly · 2023-12-31GeographyUnited States443,894,000USD0001000694-26-000007
    FY 2023Yearly · 2023-12-31ProductGrant427,323,000USD0001000694-24-000007
    FY 2023Yearly · 2023-12-31ProductMilestone Payments0USD0001000694-24-000007
    FY 2023Yearly · 2023-12-31ProductProduct531,389,000USD0001000694-24-000007
    FY 2023Yearly · 2023-12-31ProductRoyalties And Other24,993,000USD0001000694-24-000007
    FY 2023Yearly · 2023-12-31ProductSales Based Royalties8,500,000USD0001000694-24-000007
    Q3 2023Quarterly · 2023-09-30ProductGrant164,922,000USD0001000694-24-000043
    Q3 2023Quarterly · 2023-09-30ProductLicensing Royalties And Other19,833,000USD0001000694-24-000043
    Q3 2023Quarterly · 2023-09-30ProductProduct2,231,000USD0001000694-24-000043
    Q2 2023Quarterly · 2023-06-30ProductGrant137,079,000USD0001000694-23-000047
    Q2 2023Quarterly · 2023-06-30ProductProduct285,163,000USD0001000694-23-000047
    Q2 2023Quarterly · 2023-06-30ProductRoyalties And Other2,184,000USD0001000694-23-000047
    Q2 2023Quarterly · 2023-06-30ProductSales Based Royalties0USD0001000694-23-000047
    Q1 2023Quarterly · 2023-03-31ProductGrant87,379,000USD0001000694-23-000040
    Q1 2023Quarterly · 2023-03-31ProductProduct-7,457,000USD0001000694-23-000040
    Q1 2023Quarterly · 2023-03-31ProductRoyalties And Other1,029,000USD0001000694-23-000040
    Q1 2023Quarterly · 2023-03-31ProductSales Based Royalties0USD0001000694-23-000040
    FY 2022Yearly · 2022-12-31GeographyEurope826,829,000USD0001000694-25-000004
    FY 2022Yearly · 2022-12-31GeographyRest Of North America194,480,000USD0001000694-25-000004
    FY 2022Yearly · 2022-12-31GeographyRest of World577,642,000USD0001000694-25-000004
    FY 2022Yearly · 2022-12-31GeographyUnited States382,921,000USD0001000694-25-000004
    FY 2022Yearly · 2022-12-31ProductGrant382,921,000USD0001000694-23-000005
    FY 2022Yearly · 2022-12-31ProductProduct1,554,961,000USD0001000694-23-000005
    FY 2022Yearly · 2022-12-31ProductRoyalties And Other43,990,000USD0001000694-23-000005
    FY 2022Yearly · 2022-12-31ProductSales Based Royalties9,000,000USD0001000694-23-000005
    Q3 2022Quarterly · 2022-09-30ProductGrant106,273,000USD0001000694-23-000055
    Q3 2022Quarterly · 2022-09-30ProductMilestone Payments0USD0001000694-23-000055
    Q3 2022Quarterly · 2022-09-30ProductProduct626,091,000USD0001000694-23-000055
    Q3 2022Quarterly · 2022-09-30ProductRoyalties And Other2,213,000USD0001000694-23-000055
    Q3 2022Quarterly · 2022-09-30ProductSales Based Royalties1,300,000USD0001000694-23-000055
    Q2 2022Quarterly · 2022-06-30ProductGrant107,774,000USD0001000694-23-000047
    Q2 2022Quarterly · 2022-06-30ProductProduct55,455,000USD0001000694-23-000047

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.